Last update:

Oncology & Cancer news

Oncology & Cancer

Lower doses of immunotherapy for skin cancer give better results, study suggests

According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal ...

Oncology & Cancer

Virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

Patients undergoing treatment for lymphoma often experience adverse side effects that can be so severe that they stop or slow treatment. But a new study shows that a virtual program focusing on diet and exercise is a feasible ...

Oncology & Cancer

AI uncovers how DNA architecture failures trigger blood cancer

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off neighborhoods from essential services. That's what happens inside cells when the 3D structure ...

Oncology & Cancer

Antibody halts triple-negative breast cancer in preclinical models

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with ...

Oncology & Cancer

Backup DNA repair system could be cancer's weak spot

The DNA inside our cells is constantly being damaged, and one of the worst kinds of damage is a double-strand break—when both sides of the DNA helix are cut at once. Healthy cells can normally fix these breaks using highly ...

Oncology & Cancer

Simple urine test developed to screen bladder cancer

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed alternative to invasive ...

Oncology & Cancer

Update made to cervical cancer screening guideline

The American Cancer Society (ACS) released updated guidelines today for cervical cancer screening, reflecting advances in disease detection and accessibility in the United States. The updated guideline for women at average ...

Oncology & Cancer

Biomarkers link ER+ breast cancer to neighborhood poverty

Scientists have long known that Black women with estrogen-receptor positive breast cancer and those who live in disadvantaged neighborhoods often have more aggressive forms of the disease and poorer survival rates. However, ...

Oncology & Cancer

Research targets treatment resistance in neuroendocrine tumors

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for patients with advanced neuroendocrine tumors, according to new clinical trial data presented at the ...

Oncology & Cancer

Graying hair may reflect a natural defense against cancer risk

Throughout life, our cells are constantly exposed to environmental and internal factors that can damage DNA. While such DNA damage is known to contribute to both aging and cancer, the precise connection—particularly how ...

Oncology & Cancer

Precision reprogramming: How AI tricks cancer's toughest cells

Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells—hard-to-find cells that help cancers spread, come back after treatment and resist therapy. The new approach, ...

Oncology & Cancer

AI system delivers comprehensive cancer diagnosis

The Hong Kong University of Science and Technology (HKUST) today launched SmartPath, a comprehensive artificial intelligence (AI) system designed to transform the entire pathology workflow for cancer care.

Oncology & Cancer

Researchers find new way to cut cancer's lipid lifeline

Cancer thrives by hijacking the body's own basic survival systems, making it hard to attack tumors without collateral damage and side effects. Now, researchers at Cornell's Weill Institute for Cell and Molecular Biology have ...

Oncology & Cancer

Colon cancer DNA may guide tailored post-surgery care

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on risk of cancer recurrence, ...

Oncology & Cancer

Digital health outreach can improve lung cancer screening

A new multi-site study, published in JAMA, and co-led by researchers at the UNC Lineberger Comprehensive Cancer Center and Wake Forest University School of Medicine, has demonstrated that a direct-to-patient digital health ...